RFM
CVS icon

Royal Fund Management’s CVS Health CVS Stock Holding History

Royal Fund Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.78M Sell
75,179
-13,122
-15% -$1.17M 0.65% 47
2026
Q1 		$6.34M Buy
88,301
+20,472
+30% +$1.58M 0.6% 57
2025
Q4 		$5.38M Buy
67,829
+6,386
+10% +$503K 0.49% 70
2025
Q3 		$4.63M Sell
61,443
-19,102
-24% -$1.31M 0.55% 60
2025
Q2 		$5.56M Buy
80,545
+2,800
+4% +$184K 0.55% 56
2025
Q1 		$5.3M Sell
77,745
-1,266
-2% -$75.8K 0.59% 53
2024
Q4 		$3.57M Sell
79,011
-93,149
-54% -$5.23M 0.33% 95
2024
Q3 		$10.9M Buy
172,160
+101,937
+145% +$5.95M 0.65% 34
2024
Q2 		$4.17M Sell
70,223
-4,010
-5% -$251K 0.34% 66
2024
Q1 		$5.92M Buy
74,233
+4,623
+7% +$353K 0.58% 47
2023
Q4 		$5.5M Sell
69,610
-9,090
-12% -$647K 0.61% 43
2023
Q3 		$5.49M Buy
78,700
+12,141
+18% +$860K 0.74% 36
2023
Q2 		$4.6M Buy
66,559
+8,037
+14% +$572K 0.57% 57
2023
Q1 		$4.35M Buy
58,522
+2,752
+5% +$231K 0.62% 60
2022
Q4 		$5.2M Buy
55,770
+1,716
+3% +$166K 0.83% 39
2022
Q3 		$5.16M Sell
54,054
-5,472
-9% -$542K 0.94% 35
2022
Q2 		$5.51M Buy
59,526
+689
+1% +$67.2K 0.92% 36
2022
Q1 		$5.95M Sell
58,837
-2,036
-3% -$214K 0.86% 32
2021
Q4 		$6.28M Sell
60,873
-1,298
-2% -$120K 0.9% 33
2021
Q3 		$5.28M Buy
62,171
+141
+0.2% +$11.8K 0.77% 41
2021
Q2 		$5.17M Sell
62,030
-1,292
-2% -$106K 0.86% 38
2021
Q1 		$4.76M Buy
63,322
+388
+0.6% +$28.3K 0.87% 42
2020
Q4 		$4.3M Buy
62,934
+11,265
+22% +$733K 0.91% 42
2020
Q3 		$3.02M Buy
51,669
+7,978
+18% +$496K 0.77% 59
2020
Q2 		$2.84M Buy
43,691
+6,797
+18% +$428K 1% 46
2020
Q1 		$2.19M Buy
36,894
+35,065
+1,917% +$2.34M 0.89% 41
2019
Q4 		$135K Sell
1,829
-184
-9% -$12.9K 0.03% 175
2019
Q3 		$126K Buy
2,013
+243
+14% +$14.4K 0.04% 171
2019
Q2 		$96K Hold
1,770
– – 0.03% 182
2019
Q1 		$95K Hold
1,770
– – 0.03% 166
2018
Q4 		$115K Buy
1,770
+1,008
+132% +$75.2K 0.05% 140
2018
Q3 		$59K Buy
762
+161
+27% +$11.5K 0.02% 181
2018
Q2 		$38K Hold
601
– – 0.01% 222
2018
Q1 		$37K Buy
601
+525
+691% +$37.7K 0.01% 217
2017
Q4 		$5K Buy
+76
New +$5.53K ﹤0.01% 479
2017
Q3 		– Sell
-633
Closed -$50K – 468
2017
Q2 		$50K Buy
633
+26
+4% +$2.05K 0.02% 155
2017
Q1 		$47K Buy
+607
New +$48.5K 0.02% 157

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Royal Fund Management's CVS Position: Q2 2026 in Review

Royal Fund Management reduced its CVS Health (CVS) stake by 15% in Q2 2026, selling an estimated $1.17M and leaving 75,179 shares worth $7.78M. The position accounts for 0.65% of the portfolio, ranked #47.

Royal Fund Management first reported a position in CVS in Q1 2017 and has held it in 37 quarters since. The position peaked at $10.9M in Q3 2024. 459 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Royal Fund Management held 75,179 shares of CVS Health worth $7.78M as of Q2 2026.
  • Royal Fund Management sold 13,122 CVS Health shares in Q2 2026, an estimated $1.17M.
  • CVS Health made up 0.65% of Royal Fund Management's portfolio in Q2 2026, its #47 holding.
  • Royal Fund Management first reported a position in CVS Health in Q1 2017 and has held it in 37 quarters since.
  • Royal Fund Management's CVS Health position peaked at $10.9M in Q3 2024.
  • 459 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.